Connect with us
Owkin, in partnership with Servier, is organizing a global AI hackathon to accelerate glioblastoma research. Over 100 experts will analyze patient data, including multi-omics and spatial...
French fintech Swan raised €42 million in the second part of its Series B, led by Eight Roads Ventures, bringing total funding to €79 million. Specializing...
Morrison’s founders balanced jobs while growing their sneaker brand, securing a major collaboration with Mahou in under a year. The partnership boosted visibility nationwide, leading them...
Italian utility A2A and France’s Île-de-France Mobilités issued landmark European Green Bonds under the new EuGBS, highlighting strong investor demand. While the standard enhances transparency and...
Benchling’s 2024 Biopharma Technology Landscape reveals that 67% of large biopharma companies use AI, compared to 23% of small firms. AI accelerates drug discovery, yet challenges...
Ripple's XRPL network introduced the "Clawback" feature to enhance security and regulatory compliance in DeFi. It allows transaction corrections and fund freezes, benefiting XRP and RLUSD....
The bond market continues its downward trend amid rising bank liquidity deficits and Bank Al-Maghrib's interventions. Long-term rates are declining, supported by prudent Treasury management. Primary...
A study in Nature Mental Health reveals a genetic link between ADHD and cannabis use disorder (CUD). Researchers found 36 overlapping genetic loci, particularly affecting impulse...
Bitcoin’s fall below $100,000 has unsettled investors, driven by global financial uncertainty, rising interest rates, and network developments. Market sentiment shifted to fear, triggering sell-offs and...
Flomics Biotech’s liquid biopsy detects five cancers—colon, lung, prostate, pancreas, and breast—with 92% accuracy. Using RNA biomarkers, AI, and next-generation sequencing, it identifies early-stage cancer with...